ASH 66th Annual Meeting & Exposition: Friday Satellite Symposia


Sharing Best Practices from the ALL/LBL Clinic: Navigating Patient-Centered Care with Asparaginase Therapies

This program is supported by Jazz Pharmaceuticals, Inc.


3:00 p.m. - 6:00 p.m. Pacific time


ACCESS PROGRAM HERE


Marriott Marquis San Diego Marina
Marriott Grand Ballroom 5-6

On Demand program will be available here December 21, 2024.

Access Program Here

On Demand program will be available here December 21, 2024.

This 90-minute patient-centric symposium will explore navigating the patient journey with asparaginase therapies as part of the treatment strategy for acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). The lively and engaging format will feature a series of video-based clinical vignettes, each modeling best practices in patient-clinician communication, contextualized within a review of the essential role of currently available asparaginase therapies in the optimal management of ALL/LBL. Faculty commentary and expert guidance will focus on how to select therapy, assess treatment efficacy, and recognize and manage the wide range of potential toxicities associated with asparaginase treatment. The expert faculty panel will include an adult hematologist/oncologist, a pediatric hematologist/oncologist, a hematologic oncology nurse specialist, and a patient advocate.

Chair:

Ibrahim Aldoss, MD
City of Hope Duarte Cancer Center
Duarte, CA

Speakers:

Sandra Kurtin, PhD, ANP-BC, AOCN, FAPO
Clinical Assistant Professor of Medicine
Tucson, AZ

Luke Maese, DO
University of Utah, Huntsman Cancer Institute, Primary Children’s Hospital
Salt Lake City, UT

Cate O'Reilly, MSW
Patient and Caregiver Advocate, Cancer Support Community
Washington, DC

Vikki Chavis , Medscape
Email: vchavis@medscapelive.com